Neuraxis Inc
NRXS3.180USD
+0.300+10.42%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
31.44MMarket Cap
LossP/E TTM
More Details of Neuraxis Inc Company
Neuraxis, Inc. is a medical technology company. The Company is focused on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults. It focuses on advancing science and leveraging evidence-based medicine to drive the adoption of its IB-Stim therapy, which is its proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology, by the medical, scientific, and patient communities. IB-Stim is a food and drug administration (FDA) cleared for functional abdominal pain associated with irritable bowel syndrome (IBS) in adolescents 11-18 years old. The Company’s second product, the Rectal Expulsion Device (RED), is indicated to evaluate the neuromuscular function of a patient’s ability to expel its contents from the rectum and as a qualitative test for rectal hypersensitivity. RED (K242304, 2024) helps identify patients with rectal hypersensitivity who experience a desire or urge defecating at lower volumes of distension.
Neuraxis Inc Info
Ticker SymbolNRXS
Company nameNeuraxis Inc
IPO dateAug 09, 2023
CEOCarrico (Brian Allen)
Number of employees21
Security typeOrdinary Share
Fiscal year-endAug 09
Address11611 N. Meridian St
CityCARMEL
Stock exchangeNASDAQ OMX – NASDAQ Basic Amex
CountryUnited States of America
Postal code46032
Phone18126890791
Websitehttps://neuraxis.com/
Ticker SymbolNRXS
IPO dateAug 09, 2023
CEOCarrico (Brian Allen)
Company Executives of Neuraxis Inc
Name
Name/Position
Position
Shareholding
Change
Dr. Christopher Robin (Chris) Brown
Dr. Christopher Robin (Chris) Brown
Director
Director
792.84K
--
Mr. Brian Carrico
Mr. Brian Carrico
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
20.12K
--
Ms. Kristin A. Ferge
Ms. Kristin A. Ferge
Independent Director
Independent Director
14.34K
--
Mr. Timothy R. Henrichs
Mr. Timothy R. Henrichs
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Thomas Carrico
Dr. Thomas Carrico
Chief Regulatory Officer, Compliance Officer and Privacy Officer
Chief Regulatory Officer, Compliance Officer and Privacy Officer
--
--
Ms. Beth Keyser
Ms. Beth Keyser
Independent Director
Independent Director
--
--
Mr. Gil Aharon
Mr. Gil Aharon
Independent Director
Independent Director
--
--
Dr. Adrian Miranda
Dr. Adrian Miranda
Chief Medical Officer, Senior Vice President - Science and Technology
Chief Medical Officer, Senior Vice President - Science and Technology
--
-100.00%
Mr. Bradley Mitch Watkins
Mr. Bradley Mitch Watkins
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Name
Name/Position
Position
Shareholding
Change
Dr. Christopher Robin (Chris) Brown
Dr. Christopher Robin (Chris) Brown
Director
Director
792.84K
--
Mr. Brian Carrico
Mr. Brian Carrico
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
20.12K
--
Ms. Kristin A. Ferge
Ms. Kristin A. Ferge
Independent Director
Independent Director
14.34K
--
Mr. Timothy R. Henrichs
Mr. Timothy R. Henrichs
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Thomas Carrico
Dr. Thomas Carrico
Chief Regulatory Officer, Compliance Officer and Privacy Officer
Chief Regulatory Officer, Compliance Officer and Privacy Officer
--
--
Ms. Beth Keyser
Ms. Beth Keyser
Independent Director
Independent Director
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Mon, Nov 17
Updated: Mon, Nov 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Hannasch (Brian)
10.62%
Brown (Christopher Robin)
7.44%
Bigger Capital Funds, LP
7.17%
AIGH Capital Management, LLC.
2.79%
District 2 Capital LP
1.42%
Other
70.55%
Shareholders
Shareholders
Proportion
Hannasch (Brian)
10.62%
Brown (Christopher Robin)
7.44%
Bigger Capital Funds, LP
7.17%
AIGH Capital Management, LLC.
2.79%
District 2 Capital LP
1.42%
Other
70.55%
Shareholder Types
Shareholders
Proportion
Individual Investor
18.90%
Hedge Fund
8.95%
Private Equity
2.79%
Investment Advisor
2.58%
Investment Advisor/Hedge Fund
1.68%
Venture Capital
0.24%
Other
64.87%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
29
1.61M
16.14%
+370.29K
2025Q2
29
2.67M
34.65%
-516.73K
2025Q1
31
4.67M
62.21%
+933.75K
2024Q4
29
4.04M
56.27%
+476.54K
2024Q3
28
3.89M
54.36%
+476.60K
2024Q2
27
3.62M
51.12%
+229.93K
2024Q1
18
1.89M
32.23%
+1.25M
2023Q4
18
2.14M
36.50%
+1.56M
2023Q3
14
2.07M
34.17%
+2.07M
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Hannasch (Brian)
1.13M
11.46%
+430.56K
+61.42%
Jul 01, 2025
Brown (Christopher Robin)
792.84K
8.03%
--
--
Mar 31, 2025
AIGH Capital Management, LLC.
297.44K
3.01%
+277.57K
+1397.01%
Jun 30, 2025
Parsons Capital Management, Inc.
116.73K
1.18%
--
--
Jun 30, 2025
Worth Venture Partners, LLC
102.56K
1.04%
+102.56K
--
Jun 30, 2025
The Vanguard Group, Inc.
27.98K
0.28%
--
--
Jun 30, 2025
Geode Capital Management, L.L.C.
24.28K
0.25%
-692.00
-2.77%
Jun 30, 2025
Citadel Advisors LLC
25.52K
0.26%
-1.30K
-4.84%
Jun 30, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Neuraxis Inc?
The top five shareholders of Neuraxis Inc are:
Hannasch (Brian) holds 1.13M shares, accounting for 11.46% of the total shares.
Brown (Christopher Robin) holds 792.84K shares, accounting for 8.03% of the total shares.
AIGH Capital Management, LLC. holds 297.44K shares, accounting for 3.01% of the total shares.
Parsons Capital Management, Inc. holds 116.73K shares, accounting for 1.18% of the total shares.
Worth Venture Partners, LLC holds 102.56K shares, accounting for 1.04% of the total shares.
Hannasch (Brian) holds 1.13M shares, accounting for 11.46% of the total shares.
Brown (Christopher Robin) holds 792.84K shares, accounting for 8.03% of the total shares.
AIGH Capital Management, LLC. holds 297.44K shares, accounting for 3.01% of the total shares.
Parsons Capital Management, Inc. holds 116.73K shares, accounting for 1.18% of the total shares.
Worth Venture Partners, LLC holds 102.56K shares, accounting for 1.04% of the total shares.
What are the top three shareholder types of Neuraxis Inc?
The top three shareholder types of Neuraxis Inc are:
Hannasch (Brian)
Brown (Christopher Robin)
Bigger Capital Funds, LP
Hannasch (Brian)
Brown (Christopher Robin)
Bigger Capital Funds, LP
How many institutions hold shares of Neuraxis Inc (NRXS)?
As of 2025Q3, 29 institutions hold shares of Neuraxis Inc, with a combined market value of approximately 1.61M, accounting for 16.14% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -18.51%.
What is the biggest source of revenue for Neuraxis Inc?
In --, the -- business generated the highest revenue for Neuraxis Inc, amounting to -- and accounting for --% of total revenue.
